| Financial Year |
March 31 2023 |
| Monetary Funds |
6,133,264,033.98 |
| Held-for-trading Financial Assets |
2,928,192,780.82 |
| Notes Receivable |
328,747,431.27 |
| Accounts Receivable |
1,241,361,423.76 |
| Advances to Suppliers |
29,074,612.48 |
| Other Receivables |
90,493,383.07 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,814,760,651.60 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
355,154,198.73 |
| Total Current Assets |
13,014,465,007.91 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
5,058,468,910.30 |
| Under-construction Projects |
761,770,093.86 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
407,936,904.61 |
| R&D expenses |
-- |
| Goodwill |
226,333,336.57 |
| Long-Term Deferred and Prepaid Expenses |
22,549,116.88 |
| Deferred Income Tax Assets |
175,930,203.77 |
| Other Non-Current Assets |
39,782,446.49 |
| Sub-Total of Non-Current Assets |
6,730,141,905.01 |
| Total Assets |
19,744,606,912.92 |
| Short-Term Loans |
103,568,727.62 |
| Trading Financial liabilities |
-- |
| Notes Payable |
58,237,269.35 |
| Accounts Payable |
524,051,790.68 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
107,362,985.24 |
| Taxes Payable |
132,243,279.79 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
62,849,565.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
33,547,551.71 |
| Other Current Liabilities |
132,521,982.56 |
| Sub-Total of Current Liabilities |
1,182,226,994.27 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
372,418.87 |
| Deferred Income Tax Liabilities |
243,798,369.89 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,135,435,414.47 |
| Total Liabilities |
2,317,662,408.74 |
| Paid-In Capital(Or Share Stock) |
1,916,497,371.00 |
| Capital Surplus |
6,218,241,052.57 |
| Surplus Reserve |
1,131,138,251.24 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
8,206,546,640.00 |
| Minority Stockholder's Interest |
3,825,721.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
17,423,118,783.07 |
| Owner's Equity（Stockholder's Equity） |
17,426,944,504.18 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
19,744,606,912.92 |
